The new joint hypertension guidelines of the European Society of Hypertension and European Society of Cardiology will simultaneously be published in August, 2018 in the J. Hypertension and Eur. Heart J. on the diagnostics, evaluation, treatment and follow up of hypertensive patients. This guidelines put emphasis on definition, and therapeutic strategies in patients with high cardiovascular risk. In this paper I summarise the cardiovascular risk factors and put emphasis on possibilities of reduction of cardiovascular risk.
|Translated title of the contribution||Pharmacotherapeutic strategies on treatment of patients with high cardiovascular risk based on the 2018 european hypertension guidelines|
|Number of pages||4|
|Journal||Lege Artis Medicinae|
|Publication status||Published - Jul 1 2018|
ASJC Scopus subject areas